Brief: Biomerieux FY Net Profit At EUR 432 Mln

Biomerieux SA

07/03/2025 06:09

March 7 (Reuters) - Biomerieux SA BIOX.PA:

FY REVENUE EUR 3.98 BILLION

OUTLOOK FOR 2025 : SALES GROWTH OF AT LEAST 7% AT CONSTANT EXCHANGE RATES AND SCOPE OF CONSOLIDATION

OUTLOOK 2025: OPERATING INCOME RECURRING SHOULD GROW BY AT LEAST +10% AT CONSTANT EXCHANGE RATES AND SCOPE OF CONSOLIDATION

OUTLOOK FOR 2025: PROFIT FROM RECURRING OPERATIONS SHOULD GROW BY AT LEAST 10% AT CONSTANT EXCHANGE RATES AND SCOPE OF CONSOLIDATION

OUTLOOK 2025:  THE CURRENCY EFFECT SHOULD HAVE A NEGATIVE IMPACT OF AROUND -30 MILLION EUROS IN 2025 COMPARED WITH 2024

FY NET PROFIT GROUP SHARE EUR 432 MILLION

GO 28 STRATEGIC PLAN AIMS TO ACHIEVE SALES GROWTH OF +7% CAGR AT CONSTANT RATES AND SCOPE OVER THE PERIOD 2024/2028

THE CURRENCY EFFECT IS EXPECTED TO HAVE A NEGATIVE IMPACT OF AROUND €30 MILLION IN 2025 COMPARED WITH 2024.

PROPOSES DIVIDEND OF EUR 0.90 PER SHARE

Source text

Further company coverage: BIOX.PA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))